RecruitingNot ApplicableNCT07203911

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial


Sponsor

Tobias Todsen

Enrollment

200 participants

Start Date

Sep 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to improve the surgical treatment of patients with oral cancer. We will explore whether the use of surgeon performed ultrasound during these surgeries result in better tumor removal. We hypothesize that using intraoperative ultrasound to assist the resection results in more frequent clear surgical margins in oral cancer surgeries compared to standard methods. This improvement is associated with a reduced need for post-operative adjuvant therapies such as radiotherapy and reoperation, lower mortality rates, lower cancer recurrence, and enhanced quality of life for patients undergoing surgery for oral cancer. Participants will be randomized to either the control or intervention group: * Control group will receive standard treatment for oral cancer. * Intervention group will in addition to the standard treatment have surgery performed using ultrasound to guide the resection and evaluate resection margins intraoperatively. Outcomes: * Number of free surgical margins between control and intervention group. * Intraoperative surgeon assessed surgical margins compared to final histology report. * Dysphagia and quality of life questionnaires. * Recurrence rates. * Mortality rates. All participant will be followed-up at 3 months and 12 months with: * MDADI dysphagia questionnaire * EORTC head and neck cancer quality of life questionnaire * Follow-up on recurrrence and mortality.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether surgeons using a portable ultrasound device in real time during oral cancer surgery can improve their ability to achieve clear margins — meaning removing the cancer with enough healthy tissue around it to reduce the chance of the cancer coming back. Getting clear margins is one of the most important factors in preventing recurrence. **You may be eligible if...** - You have been diagnosed with oral squamous cell carcinoma (a common type of mouth cancer) that is stage T1, T2, or T3 - You are scheduled for surgical removal of the cancer - You are 18 or older - You are able to understand written and verbal instructions **You may NOT be eligible if...** - You are younger than 18 - Your cancer is suspected to have grown into the jawbone - Your tumor cannot be seen clearly on ultrasound - You have previously had radiation therapy to the mouth or throat area - You are unable to understand the information given about the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTUltrasound imaging

Ultrasound will be performed during surgery in two phases: 1) in-vivo and 2) ex-vivo. In the in-vivo phase surgeons will perform intraoral ultrasound with a small intraoral transducer in order to visualize size and boundaries of tumor. Then the surgeon begins the resection periodically pausing to obtain real-time images of the resection plane and determin if resection is performed at safe distance to the tumor. In the ex-vivo phase the resected tumor will undergo ultrasound by using a motorized mechanical arm designed to hold an ultrasound transducer. This ensures standardized and reproducible scans. The purpose of the ex-vivo scan is to measure the surgical margins at the operating theatre and allow for an immediate re-resection of necessary. Surgeons in the intervention group will also have the possibility of taking biopsies for frozen section analyses.

OTHERStandard Treatment

Standard surgical treatment of oral cancer


Locations(7)

Stanford Otolaryngology - Head & Neck Surgery Department

Stanford, California, United States

Emory University Hospital

Atlanta, Georgia, United States

Department of Otorhinolaryngology Head and Neck Surgery

Aarhus, Denmark

Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet

Copenhagen, Denmark

Istituto Nazionale Tumori of Milan

Milan, Italy

Groote Schuur

Cape Town, South Africa

Karolinska Institute

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07203911


Related Trials